RBC Transfusion in premature neonates in Mofid Children Hospital 2017
Journal Title: Khoon - Year 2018, Vol 15, Issue 1
Abstract
RBC Transfusion in premature neonates in Mofid Children Hospital 2017 Tajjali S.1, Tatarpour P.2, Fallahi M.1 1Neonatal Health Research Center (NHRC), Mofid Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran 2School of Nursing & Midwifery, Iran University of Medical Sciences, Tehran, Iran Abstract Background and Objectives Premature neonates are extremely vulnerable in the neonatal pe¬riod, as is attested to by the high rates of infant mortal¬ity. Infants that are hospitalized are likely to have at least one blood transfusion. Anemia is one of the most common side effects. The purpose of this cross sectional descriptive study was outcome of red blood cell injection in preterm infants admitted to the NICU of the Mofid Hospital at 2016. Materials and Methods For this descriptive cross-sectional study, 116 preterm infants weighing ≤ 1500 grams and gestational age ≤ 35 weeks who had no history of surgical and congenital anomalies were admitted to NICU. The data were analyzed by SPSS 20 and dependent t-test. Results Data were collected, apnea 79.31%, 19.82% ,tachycardia 80.17% ,48.27% and residue 55.73%, 21.34% before and after blood transfusion respectively according to nursing reports. Before and after transfusion mean of hemoglobin was 9.1 mg/dl and 11.8 mg/dl and hematocrit was 25.6% and 32.5%, respectively. Conclusions Finding show apnea (p = 0.001), tachycardia (p = 0.004), residue (p = 0.005), hemoglobin (p = 0.001) and hematocrit (p = 0.001). For prescription, Considering Clinical manifestations and laboratory findings, improves laboratory, clinical and ventilator conditions in premature infants. Key words: Anemia, Blood Transfusion, Red Blood Cells Received: 16 Apr 2017 Accepted: 13 Feb 2018 Correspondence: Tatarpour P., MSc of Internal Nursing & Surgery. Instructor of School of Nursing & Midwifery, Iran University of Medical Sciences. Valiasr St. Postal Code: 1996713883, Tehran, Iran. Tel: (+9821) 43651000; Fax: (+9821) 88201978 E-mail: p.tatarpoor@gmail.com
Authors and Affiliations
S. Tajjali, P. Tatarpour, M. Fallahi
Keywords
Related Articles
- EP ID EP321625
- DOI -
- Views 83
- Downloads 0
The Significance of Ubiquitin-Proteasome Pathway in Glucocorticoid Resistance Development in Acute Lymphoblastic Leukemia
The Significance of Ubiquitin-Proteasome Pathway in Glucocorticoid Resistance Development in Acute Lymphoblastic Leukemia Dehghan-Nayeri N.1, Eshghi P.2,3, Goudarzi Pour K.2,3, Darvishi M.1, Gharehbaghian A.1,2 1Schoo...
Comparative survey of problems in thalassemia major patients with regular and irregular follow ups of therapeutic principles
Comparative survey of problems in thalassemia major patients with regular and irregular follow ups of therapeutic principles Tabarsi B.1(MS), Marbaghi A.2(MS), Safavi M.1(PhD), Afkhami M.3(BS) 1 Azad University o...
تشخيص فيوژنهاي ناشي از ترانس لوكاسيونهاي كروموزومي فيلادلفيا در بيماران ايراني مبتلا به لوسمي ميلوئيدي مزمن
تشخيص فيوژنهاي ناشي از ترانس لوكاسيونهاي كروموزومي فيلادلفيا در بيماران ايراني مبتلا به لوسمي ميلوئيدي مزمن دكتر سيد حميداله غفاري1، مرجان يغمايي2، دكتر كامران علي مقدم3، دكتر اردشير قوامزاده4، دكتر محمد جهاني4،...
The use of blood and blood products in Vali-e Asr Educational Hospital (Birjand, Iran)
The use of blood and blood products in Vali-e Asr Educational Hospital (Birjand, Iran) Najafzadeh M.1, Zardast M.2, Assari F.3, Anani Sarab Gh.R.4, Sajjadi S.M.5 1Student Research Committee, Birjand University of Med...
Non-Conforming Product, Monitoring and Improvement
Non-Conforming Product, Monitoring and Improvement Amini Kafi-abad S.1, Pourfathollah A.A.1,2, Maghsudlu M.1, Asadi S.1,3, Baradaran M.H.1,4, Pooriani E.1,5, Taghvaie N.1,6, Hoseini M.1,7, Hoseini M.M.A.1,8, Khosravi S....